retatrutide clinical trial phase Eli Lilly's 3 studies investigating retatrutide, the "triple-G" agonist, have found that long-term use can achieve substantial weight loss. Read about the work via the link in the comments This Triple Action Peptide is

Advantages of Triple Agonist Activity Retatrutides triple action is a big plus

According to the American Diabetes Association's Standards of Medical Care in Diabetes, proper injection technique and systematic site rotation are essential for optimal medication absorption and to prevent lipohypertrophy (thickening of fatty tissue) or lipoatrophy (loss of fatty tissue) at injection sites

Available from: Peterli R, Wlnerhanssen BK, Peters T, et al

Jan 20, 2026 9 min read READ MORE Fitness GLP-1 and Strength Training: Avoiding a Common Pitfall Losing weight on a GLP-1 medication

This approach reduces the long-term side effect burden and cost of peptide therapy

The technical challenges are steep